QuidelOrtho (QDEL) Research & Development (2021 - 2024)

QuidelOrtho has disclosed Research & Development across 4 years of filings, most recently posting $59.2 million for Q1 2024.

• In Q1 2024, Research & Development fell 4.98% year-over-year to $59.2 million; the TTM figure through Mar 2024 stood at $303.2 million (up 8.13% YoY), while the FY2024 annual figure was $218.7 million, down 10.73% from the prior year.
• Research & Development came in at $59.2 million for Q1 2024 at QuidelOrtho, down from $118.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $118.8 million in Q4 2023 to a low of $22.6 million in Q3 2021.
• Average Research & Development over 4 years is $59.7 million, with a median of $62.3 million recorded in 2023.
• Year-over-year, Research & Development surged 176.79% in 2022 and slipped 4.98% in 2024.
• Over 4 years, Research & Development stood at $23.7 million in 2021, then surged by 176.79% to $65.6 million in 2022, then jumped by 81.1% to $118.8 million in 2023, then tumbled by 50.17% to $59.2 million in 2024.
• Per Business Quant data, the three most recent Research & Development figures were $59.2 million in Q1 2024, $118.8 million in Q4 2023, and $62.4 million in Q4 2023.